Iovance Biotherapeutics Inc (IOVA)
8.24
+0.10
(+1.23%)
USD |
NASDAQ |
Nov 21, 16:00
8.20
-0.04
(-0.49%)
After-Hours: 20:00
Iovance Biotherapeutics Profit Margin (Quarterly): -142.7% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -142.7% |
| June 30, 2024 | -312.2% |
| March 31, 2024 | -15.80K% |
| Date | Value |
|---|---|
| December 31, 2023 | -24.15K% |
| September 30, 2023 | -24.26K% |
| June 30, 2023 | -44.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-44.76K%
Minimum
Jun 2023
-142.7%
Maximum
Sep 2024
-18.24K%
Average
-19.97K%
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.05% |
| Xtant Medical Holdings Inc | -17.98% |
| Myomo Inc | -10.50% |
| Catheter Precision Inc | -4.29K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -58.90% |
| Return on Assets | -45.99% |
| Return on Invested Capital | -58.81% |
| Gross Profit Margin (Quarterly) | 31.99% |
| Operating Margin (Quarterly) | -152.1% |
| Return on Net Operating Assets | -84.05% |